Cargando…

Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas

Aims: Programmed death-1 (PD-1) is expressed by germinal center-associated helper T-cells and acts as a negative regulator of the immune system. PD-1 is encountered on tumor cells of angioimmunoblastic T-cell lymphoma and is a postulated diagnostic marker in chronic lymphocytic leukemia (CLL/SLL). R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muenst, S., Hoeller, S., Willi, N., Dirnhofer, S., Tzankov, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2010
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835488/ https://www.ncbi.nlm.nih.gov/pubmed/20826917 http://dx.doi.org/10.3233/DMA-2010-0725

Ejemplares similares

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study
por: Tzankov, Alexandar, et al.
Publicado: (2015)

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007)

Genetic background and evolution of relapses in aggressive B-cell lymphomas
por: Juskevicius, Darius, et al.
Publicado: (2017)

Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin
por: Vela, Visar, et al.
Publicado: (2021)

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
por: Juskevicius, Darius, et al.
Publicado: (2017)

Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature
por: Banz, Yara, et al.
Publicado: (2013)

Genomic Landscape of Hodgkin Lymphoma
por: Brune, Magdalena M., et al.
Publicado: (2021)

Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
por: Guo, Hong-Qiang, et al.
Publicado: (2010)

H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas
por: Brune, Magdalena M., et al.
Publicado: (2022)

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells
por: Burkhard, Regula, et al.
Publicado: (2019)

Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
por: Obermann, Ellen C, et al.
Publicado: (2005)

High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations
por: Pillonel, V., et al.
Publicado: (2018)

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma
por: Horvilleur, E, et al.
Publicado: (2014)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma
por: Saber, Manal Mohamed
Publicado: (2022)

Proliferation in Non-Hodgkin’S Lymphomas and Its Prognostic Value Related to Staging Parameters
por: Lorand‐Metze, Irene, et al.
Publicado: (2004)

Prognostic Value of PD-L1, PD-1 and CD8A in Canine Diffuse Large B-Cell Lymphoma Detected by RNAscope
por: Aresu, Luca, et al.
Publicado: (2021)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Grey Zone Lymphomas: Lymphomas with Intermediate Features
por: Hoeller, Sylvia, et al.
Publicado: (2012)

Lymphoid Infiltrates in B Cell Non Hodgkin’s Lymphoma: Comparing Nuclear Characteristics between Lymph Node and Bone Marrow; and Evaluating Diagnostic Features of Bone Marrow Infiltrates in Paraffin Embedded Tissues
por: Deverell, Mark H., et al.
Publicado: (1997)

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1(+) T-cell subsets
por: Chu, Fuliang, et al.
Publicado: (2014)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011)

SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers
por: Laronga, Christine, et al.
Publicado: (2004)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
por: Xing, Wei, et al.
Publicado: (2016)

Protein Profiling of B-Cell Lymphomas Using Tissue Biopsies: A Potential Tool for Small Samples in Pathology
por: Jansen, Corine, et al.
Publicado: (2008)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
por: Zheng, Zhong, et al.
Publicado: (2019)

The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
por: Garcia-Lacarte, Marcos, et al.
Publicado: (2021)

The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis
por: Qiu, Liping, et al.
Publicado: (2019)

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2023)

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018)

ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration
por: Puddinu, Viola, et al.
Publicado: (2017)

Significance of PD-L1 in the diagnosis and treatment of B-cell malignant lymphoma
por: Yang, Jianzhong, et al.
Publicado: (2019)

Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics
por: Pierceall, William E., et al.
Publicado: (2011)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
por: Brault, L, et al.
Publicado: (2012)

GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
por: Koh, Young Wha, et al.
Publicado: (2017)

Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies
por: Gravelle, Pauline, et al.
Publicado: (2017)

The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
por: Fang, Xia, et al.
Publicado: (2017)

The IL‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma
por: Hashwah, Hind, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ama1sm20hqphprmt7eg8a35tq0